Carisma Therapeutics Inc. Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

Carisma Therapeutics Inc. cash flow reinvestment rate. Carisma Therapeutics Inc. (CARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.91 Million. Explore Carisma Therapeutics Inc. (CARM) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$1.91 Million
USD

Capital Expenditures

$0.00
USD

Cash Flow Reinvestment Rate of Carisma Therapeutics Inc. (2016–2016)

Cash flow reinvestment rate of Carisma Therapeutics Inc. from 2016 to 2016. Historical reinvestment intensity for Carisma Therapeutics Inc. across 1 annual periods. Explore CARM capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Carisma Therapeutics Inc. Cash Flow Reinvestment Rate by Year (2016–2016)

Carisma Therapeutics Inc. cash flow reinvestment rate by year from 2016 to 2016. Year-by-year capital reinvestment analysis for Carisma Therapeutics Inc.. For the full cash flow conversion analysis, see CARM cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 0.00x $0.00 $2.62 Million $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow